185 related articles for article (PubMed ID: 26373628)
1. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
Loavenbruck A; Sandroni P
Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
[TBL] [Abstract][Full Text] [Related]
2. Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
[TBL] [Abstract][Full Text] [Related]
3. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
Isaacson SH; Dashtipour K; Mehdirad AA; Peltier AC
Curr Neurol Neurosci Rep; 2021 Mar; 21(4):18. PubMed ID: 33687577
[TBL] [Abstract][Full Text] [Related]
4. Orthostatic hypotension for the cardiologist.
Mar PL; Raj SR
Curr Opin Cardiol; 2018 Jan; 33(1):66-72. PubMed ID: 28984649
[TBL] [Abstract][Full Text] [Related]
5. Management of Orthostatic Hypotension.
Palma JA; Kaufmann H
Continuum (Minneap Minn); 2020 Feb; 26(1):154-177. PubMed ID: 31996627
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
[TBL] [Abstract][Full Text] [Related]
7. Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension.
Kymes SM; Sullivan C; Jackson K; Raj SR
Auton Neurosci; 2020 May; 225():102659. PubMed ID: 32200263
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension.
Mwesigwa N; Shibao CA
Hypertension; 2024 Jul; 81(7):1460-1466. PubMed ID: 38766862
[TBL] [Abstract][Full Text] [Related]
9. Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.
Cutsforth-Gregory JK; Low PA
Neurol Ther; 2019 Dec; 8(2):307-324. PubMed ID: 31456212
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort.
Beach P; McKay JL
Auton Neurosci; 2024 Jun; 253():103173. PubMed ID: 38692034
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.
Hewitt LA; Lindsten A; Gorny S; Karnik-Henry M; Kymes S; Favit A
Health Sci Rep; 2021 Mar; 4(1):e227. PubMed ID: 33521332
[TBL] [Abstract][Full Text] [Related]
12. Intra-neuronal alpha-synuclein deposition is related to cardiac noradrenergic deficiency and olfactory dysfunction in neurogenic orthostatic hypotension.
Isonaka R; Sullivan P; Holmes C; Goldstein DS
Res Sq; 2024 Mar; ():. PubMed ID: 38529504
[TBL] [Abstract][Full Text] [Related]
13. A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension .
Isonaka R; Sullivan P; Holmes C; Goldstein DS
Clin Auton Res; 2024 Jun; ():. PubMed ID: 38844644
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.
Okamoto LE; Shibao C; Gamboa A; Choi L; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
Hypertension; 2012 Mar; 59(3):650-6. PubMed ID: 22311903
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological basis of orthostatic hypotension in autonomic failure.
Smit AA; Halliwill JR; Low PA; Wieling W
J Physiol; 1999 Aug; 519 Pt 1(Pt 1):1-10. PubMed ID: 10432334
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.
Juraschek SP; Cortez MM; Flack JM; Ghazi L; Kenny RA; Rahman M; Spikes T; Shibao CA; Biaggioni I;
Hypertension; 2024 Mar; 81(3):e16-e30. PubMed ID: 38205630
[TBL] [Abstract][Full Text] [Related]
17. Advances in non-pharmacological management of Parkinson's disease complicated with blood pressure abnormalities.
Xing Q; Zhao X; Xie L; Chen X; Wang Y; Xie Y
J Physiol Pharmacol; 2023 Aug; 74(4):. PubMed ID: 37865954
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.
Palma JA; Kaufmann H
Mov Disord Clin Pract; 2017; 4(3):298-308. PubMed ID: 28713844
[TBL] [Abstract][Full Text] [Related]
19. [Afferent baroreflex failure with hyponatremia: A case report].
Peng S; Qi Y; Sun L; Li D; Wang X; Han J; Chen B; Zhang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):357-361. PubMed ID: 38595258
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic orthostatic hypotension after treatment with sorafenib.
Wegner Wippel C; Deshpande H; Patwa H; Peixoto AJ
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
